Neurogene Inc（NGNE）の財務NGNENeurogene Inc

Evaluating the bottom line, Neurogene Inc. maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -45.32%, provide a clear picture of how effectively NGNE converts its operational activities into shareholder value.

In the context of the broader market, NGNE competes directly with industry leaders such as DMAC and MNPR. With a market capitalization of $608.75M, it holds a leading position in the sector. When comparing efficiency, NGNE's gross margin of N/A stands against DMAC's N/A and MNPR's N/A. Such benchmarking helps identify whether Neurogene Inc. is trading at a premium or discount relative to its financial performance.

Neurogene has reported negative earnings per share (EPS) of -1.53 for Q2 2026, with a forward P/E ratio of 0, indicating no expected profitability in the near term. The gross margin has been 0% for the past several quarters, showing no revenue generation from operations.